Avalon Pharmaceuticals and ChemDiv, Inc. have entered into a collaboration for the discovery and development of small molecule oncology therapeutics. Avalon will use its AvalonRx platform to discover new active compounds in screens against selected targets and target pathways. ChemDiv will provide Avalon access to its Discovery outSource services platform, including the largest commercially available chemical library, as well as medicinal and synthetic chemistry for the discovery and development...